Summary
CVS Health Corporation (CVS) announced on November 26, 2012, that it entered into an Underwriting Agreement to issue and sell $1.25 billion in aggregate principal amount of 2.75% senior notes due December 1, 2022. The offering, which closed on November 29, 2012, generated net proceeds of approximately $1.238 billion after deducting underwriting discounts and estimated offering expenses. This move indicates the company's strategy to raise capital through long-term debt financing. The net proceeds from this issuance are intended to support CVS Health's ongoing operational and strategic initiatives. The notes are governed by the Senior Indenture dated August 15, 2006, with The Bank of New York Mellon Trust Company, N.A., as trustee. Investors should note the fixed interest rate of 2.75% and the maturity date of December 1, 2022, which provides a clear debt servicing schedule for the company.
Key Highlights
- 1CVS Health issued $1.25 billion of 2.75% senior notes due December 1, 2022.
- 2The notes were sold to a syndicate of underwriters led by Barclays Capital Inc., Wells Fargo Securities, LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, BNY Mellon Capital Markets, LLC, and J.P. Morgan Securities LLC.
- 3Net proceeds from the offering are approximately $1.238 billion.
- 4The offering was conducted under the company's existing Form S-3 registration statement.
- 5The notes are governed by the Senior Indenture dated August 15, 2006.
- 6The closing of the sale occurred on November 29, 2012.